Peeri N.C., Shrestha N., Rahman M.S., Zaki R., Tan Z., Bibi S., Baghbanzadeh M., Aghamohammadi N., Zhang W., Haque U. 2020. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? Int. J. Epidemiol. 49, 717–726. https://doi.org/10.1093/ije/dyaa033

Article  PubMed  Google Scholar 

Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Muller M.A., Drosten C., Pohlmann S. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181, 271–280 e278. https://doi.org/10.1016/j.cell.2020.02.052

Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. 2020. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 117, 11 727–11 734. https://doi.org/10.1073/pnas.2003138117

Article  CAS  Google Scholar 

Bayati A., Kumar R., Francis V., McPherson P.S. 2021. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 296, 100306. https://doi.org/10.1016/j.jbc.2021.100306

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S., Qiu Z., Hou Y., Deng X., Xu W., Zheng T., Wu P., Xie S., Bian W., Zhang C., Sun Z., Liu K., Shan C., Lin A., Jiang S., Xie Y., Zhou Q., Lu L., Huang J., Li X. 2021. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 31, 126–140. https://doi.org/10.1038/s41422-020-00460-y

Article  CAS  PubMed  Google Scholar 

Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. 2003. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 77, 8801–8811. https://doi.org/10.1128/jvi.77.16.8801-8811.2003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schibli D.J., Weissenhorn W. 2004. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol. Membr. Biol. 21, 361–371. https://doi.org/10.1080/09687860400017784

Article  CAS  PubMed  Google Scholar 

Huang Y., Yang C., Xu X.F., Xu W., Liu S.W. 2020. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141–1149. https://doi.org/10.1038/s41401-020-0485-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

rapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. 2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367, 1260–1263. 10.1126/science.abb250

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai Y., Zhang J., Xiao T., Peng H., Sterling S.M., Walsh R.M., Jr., Rawson S., Rits-Volloch S., Chen B. 2020. Distinct conformational states of SARS-CoV-2 spike protein. Science. 369, 1586–1592. https://doi.org/10.1126/science.abd4251

Article  CAS  PubMed  Google Scholar 

Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. 2020. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 181, 281–292 e286. https://doi.org/10.1016/j.cell.2020.02.058

Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E. 2020. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral. Res. 176, 104742. https://doi.org/10.1016/j.antiviral.2020.104742

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q., Xiang R., Huo S., Zhou Y., Jiang S., Wang Q., Yu F. 2021. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct. Target Ther. 6, 233. https://doi.org/10.1038/s41392-021-00653-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guney C., Akar F. 2021. Epithelial and endothelial expressions of ACE2: SARS-CoV-2 entry routes. J. Pharm. Pharm. Sci. 24, 84–93. https://doi.org/10.18433/jpps31455

Article  CAS  PubMed  Google Scholar 

Zhao M.M., Yang W.L., Yang F.Y., Zhang L., Huang W.J., Hou W., Fan C.F., Jin R.H., Feng Y.M., Wang Y.C., Yang J.K. 2021. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct. Target Ther. 6, 134. https://doi.org/10.1038/s41392-021-00558-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao M.M., Zhu Y., Zhang L., Zhong G., Tai L., Liu S., Yin G., Lu J., He Q., Li M.J., Zhao R.X., Wang H., Huang W., Fan C., Shuai L., Wen Z., Wang C., He X., Chen Q., Liu B., Xiong X., Bu Z., Wang Y., Sun F., Yang J.K. 2022. Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies. Cell Discov. 8, 53. https://doi.org/10.1038/s41421-022-00419-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Padmanabhan P., Desikan R., Dixit N.M. 2020. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. PLoS Comput. Biol. 16, e1008461. https://doi.org/10.1371/journal.pcbi.1008461

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasad K., Al Omar S.Y., Almuqri E.A., Rudayni H.A., Kumar V. 2021. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPR-SS2 and cathepsins B/L. PLoS One. 16, e0256141. https://doi.org/10.1371/journal.pone.0256141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasad K., Ahamad S., Kanipakam H., Gupta D., Kumar V. 2021. Simultaneous inhibition of SARS-CoV-2 entry pathways by cyclosporine. ACS Chem. Neurosci. 12, 930–944. https://doi.org/10.1021/acschemneuro.1c00019

Article  CAS  PubMed  Google Scholar 

Evans J.P., Liu S.L. 2021. Role of host factors in SARS-CoV-2 entry. J. Biol. Chem. 297, 100847. https://doi.org/10.1016/j.jbc.2021.100847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuyama S., Ujike M., Morikawa S., Tashiro M., Taguchi F. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. USA. 102, 12543–12547. https://doi.org/10.1073/pnas.0503203102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426, 450–454. https://doi.org/10.1038/nature02145

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., Penninger J.M. 2005. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875–879. https://doi.org/10.1038/nm1267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin C.R., Bahmed K., Simborio H., Hayek H., Bolla S., Marchetti N., Criner G.J., Kosmider B. 2021. Expression of SARS-CoV-2 entry factors in human alveolar type II cells in aging and emphysema. Biomedicines. 9. https://doi.org/10.3390/biomedicines9070779

Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579, 270–273. https://doi.org/10.1038/s41586-020-2012-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. 2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 367, 1444–1448. https://doi.org/10.1126/science.abb2762

Article  PubMed  PubMed Central  Google Scholar 

Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S. 2000. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 87, E1-9. https://doi.org/10.1161/01.res.87.5.e1

Article  CAS  PubMed  Google Scholar 

Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. 2000. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238–33243. https://doi.org/10.1074/jbc.M002615200

Article  CAS  PubMed  Google Scholar 

Hikmet F., Mear L., Edvinsson A., Micke P., Uhlen M., Lindskog C. 2020. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16, e9610. https://doi.org/10.15252/msb.20209610

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J., Gao J., Xu Y.P., Zhou T.L., Jin Y.Y., Lou J.N. 2007. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial cells. Zhonghua Yi Xue Za Zhi. 87, 833–837.

CAS  PubMed  Google Scholar 

Han X., Zhou Z., Fei L., Sun H., Wang R., Chen Y., Chen H., Wang J., Tang H., Ge W., Zhou Y., Ye F., Jia-ng M., Wu J., Xiao Y., Jia X., Zhang T., Ma X., Zhang Q., Bai X., Lai S., Yu C., Zhu L., Lin R., Gao Y., Wang M., Wu Y., Zhang J., Zhan R., Zhu S., Hu H., Wang C., Chen M., Huang H., Liang T., Chen J., Wang W., Zhang D., Guo G. 2020. Construction of a human cell landscape at single-cell level. Nature. 581, 303–309. https://doi.org/10.1038/s41586-020-2157-4

Article  CAS  PubMed  Google Scholar 

Chi X., Yan R., Zhang J., Zhang G., Zhang Y., Hao M., Zhang Z., Fan P., Dong Y., Yang Y., Chen Z., Guo Y., Zhang J., Li Y., Song X., Chen Y., Xia L., Fu L., Hou L., Xu J., Yu C., Li J., Zhou Q., Chen W. 2020. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 369, 650–655. https://doi.org/10.1126/science.abc6952

Article  CAS  PubMed  PubMed Central